Lyon, France, 21 May 2013 – The International Agency for Research on Cancer (IARC) has the pleasure of announcing the re-election of Dr Christopher Wild as Director of this specialized cancer research agency of the World Health Organization (WHO). The IARC Governing Council, made up of representatives of 24 Participating States plus the Director-General of WHO, reappointed Dr Wild for a second five-year term at its annual meeting in Lyon on May 16–17, 2013.

“I have had the honour and privilege to lead IARC for five years, and I look forward to taking up the challenges posed by the markedly increasing number of cancer cases globally,” said Dr Wild. “The particularly heavy burden projected to fall on the low- and middle-income …

Read more

Global Health programs are key goals of many internationally oriented Health Institutes and Organizations, and within such approach a Global Oncology program will become a major, crucial objective.

Infectious diseases are in general under control (with some emerging and re-emerging episode), life expectancy is globally increasing, and incidence as well as disease-burden of cancers (associated or not to infectious agents) will be inevitably rising. We need to develop the new clinical oncology of tomorrow and to prepare the next generation of oncologists. The aims of the section and the call for the papers is currently highlighted at the BioMed Central Blog

I do not know how popular is the English version of the Latin motto Lupus pilum mutat, non mentem, in Italian, however, it is very frequently used and even with a negative or a positive meaning. The negative component is emphasized for vices, which cannot be easily abandoned; the positive component is a strong determination, motivated stubbornness.

Last week the Latin motto with the positive meaning came to my mind at the end of the Lectio Magistralis on The role of pathogens in human cancers, held on Friday April 12th at Istituto Nazionale Tumori “Fond Pascale” Naples-IT, by the Nobel Laureate Prof. Dr. Harald zur Hausen. A Nobel Laureate in Medicine (2008), retired almost 10 years ago, could be just …

Read more

A new short video has just been released highlighting Burkitt Lymphoma and EMBLEM activities in this area, including information on the Workshop in Mwanza last September.

The video was a collaborative project bringing local groups together to empower and recognize people who are working in the Burkitt Lymphoma area. The animation in the video was completed by students.

GVN’s Three Action Platforms

1. Support for cutting edge research
GVN supports its scientists through small grants that allow new lines of research to move forward. To ensure that medical virologists are in place to address future, yet unimagined viral challenges, GVN provides training fellowships for tomorrow’s leaders. GVN scientists share ideas and information to avoid duplicative research. And, in outbreak situations, GVN experts stand ready to provide critical insights that will be integral for containment and prevention measures.

2. Public education
GVN provides authoritative science-driven information to the public and policymakers about viruses and vaccines through a spectrum of outreach initiatives and digital forums.

3. Advocacy
GVN works with governments and research funding agencies worldwide to ensure …

Read more